tldrdailynews.com logo

Pliant's Lead Drug Shows Promising Results in Chronic Liver Disease Study

1 min read
Source: Endpoints News
Pliant's Lead Drug Shows Promising Results in Chronic Liver Disease Study
Photo: Endpoints News
TL;DR

Pliant Therapeutics has reported positive early-stage results from an exploratory study, indicating that patients with chronic liver disease who received its drug, bexotegrast, showed improved liver function compared to those who received a placebo. The study showed reduced levels of liver scarring biomarkers in patients who received the drug.

Topics:businesshealth#biomarkers#chronic-liver-disease#drug-study#health#liver-function#pliant-therapeutics
Share this article
  1. Pliant shares spike on exploratory study results of lead drug in chronic liver disease  Endpoints News
  2. Pliant bends investors to its will, sending stock up with early evidence of efficacy in liver disease  FierceBiotech
  3. Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis  GlobeNewswire
  4. View Full Coverage on Google News

Want the full story? Read the original reporting

Read on Endpoints News